IVIM Health vs LifeMD (2026): prices, structure, verdict
On tirzepatide, IVIM Health↗ is cheaper: $278 versus $597 a month all-in — a $319 monthly gap, $3,828 across a year of maintenance dosing.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
On semaglutide, IVIM Health is cheaper: $149 versus $348 a month all-in — a $199 monthly gap, $2,388 across a year of maintenance dosing.
IVIM Health
- Tirzepatide all-in
- $278/mo
- Semaglutide all-in
- $149/mo
- 12-mo tirzepatide (best path)
- $3,336
- Membership
- $75/mo (inside figures)
- Shipping
- included
- Commitment
- membership mandatory for duration
- Cancellation
- membership mandatory
- Pharmacy
- not named
- States
- not published
- Insurance
- no
- Evidence
- source-verified · 2026-08-05
LifeMD
- Tirzepatide all-in
- $597/mo · flat
- Semaglutide all-in
- $348/mo · flat
- 12-mo tirzepatide (best path)
- $7,164
- Membership
- $149/mo (inside figures)
- Shipping
- included
- Commitment
- program fee recurs monthly
- Cancellation
- program fee recurs until cancelled
- Pharmacy
- not named
- States
- 50 states
- Insurance
- yes
- Evidence
- third-party reported · 2026-08-05
The two records, condensed
IVIM Health: the record, condensed
IVIM Health’s tirzepatide program bills $278 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Pricing steps with the dose here: from $208 at entry to $278 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $840 a year, which is why every ranking on this site uses the larger number.
The all-in figure already contains a compulsory $75 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $203 would be exactly that kind of mirage.
Context for that figure: it ranks #3 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife↗, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.
IVIM Health’s semaglutide program bills $149 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.
A required $75/month membership is part of the deal, and part of the figure above: $74 of medication plus $75 of platform equals the $149 that leaves your account. Judge the membership by what it includes, but compare on the total.
To place the number: #3 of 20 verified programs, with the floor $16/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $200 a month. A year at this figure: $1,788 monthly-billed.
Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗
LifeMD: the record, condensed
Start with the load-bearing figure: $597 a month, all-in, is what LifeMD charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Inside that $597 sits a mandatory $149-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $448, and it is not a price anyone can actually pay, because the membership cannot be declined.
Context for that figure: it ranks #17 of 17 in the verified tirzepatide index — $382/month above the floor (NexLife, $215) — and sits $148 over the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $7,164.
Start with the load-bearing figure: $348 a month, all-in, is what LifeMD charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
The all-in figure already contains a compulsory $149 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $199 would be exactly that kind of mirage.
To place the number: #20 of 20 verified programs, with the floor $215/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $1 a month. A year at this figure: $4,176 monthly-billed.
Operationally at LifeMD: shipping included; commitment program fee recurs monthly; cancellation program fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: 50 states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the LifeMD page · visit LifeMD ↗
Tirzepatide: the duel in full
The tirzepatide arithmetic between these two is short: $278 (IVIM Health) against $597 (LifeMD). $319 a month sounds survivable; $3,828 a year is a decision.
Structure sharpens the gap: LifeMD’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while IVIM Health’s is not — so LifeMD’s number is a ceiling and IVIM Health’s advertised entry ($208) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.
Both totals carry mandatory memberships inside them — $75 at IVIM Health, $149 at LifeMD — so the medication-only prices the ads may quote ($203 and $448) are both fictions no one can actually pay.
Semaglutide: the duel in full
Put the two semaglutide figures side by side and hold them there: IVIM Health at $149, LifeMD at $348 — a $199 monthly spread that compounds to $2,388 over a maintenance year and $4,776 over two.
Structure sharpens the gap: LifeMD’s figure is dose-flat (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill the same), while IVIM Health’s is not — so LifeMD’s number is a ceiling and IVIM Health’s advertised entry ($149) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.
Both totals carry mandatory memberships inside them — $75 at IVIM Health, $149 at LifeMD — so the medication-only prices the ads may quote ($74 and $199) are both fictions no one can actually pay.
Translate the $319/month spread into medication: $3,828 a year equals roughly 13.8 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.
On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: IVIM Health $278/mo month-to-month versus LifeMD $597/mo month-to-month. Same winner on both bases — IVIM Health leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.
Three, six, twelve, twenty-four months — best path each way
3 months: IVIM Health $834 monthly; LifeMD $1,791 monthly — best path favors IVIM Health by $957. 6 months: IVIM Health $1,668 monthly; LifeMD $3,582 monthly — best path favors IVIM Health by $1,914. 12 months: IVIM Health $3,336 monthly; LifeMD $7,164 monthly — best path favors IVIM Health by $3,828. 24 months: IVIM Health $6,672 monthly; LifeMD $14,328 monthly — best path favors IVIM Health by $7,656.
Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.
The same clock, on semaglutide
3 mo: IVIM Health $447 vs LifeMD $1,044 — $597 to IVIM Health. 6 mo: IVIM Health $894 vs LifeMD $2,088 — $1,194 to IVIM Health. 12 mo: IVIM Health $1,788 vs LifeMD $4,176 — $2,388 to IVIM Health. 24 mo: IVIM Health $3,576 vs LifeMD $8,352 — $4,776 to IVIM Health.
Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.
Everything besides the price
Coverage: IVIM Health publishes “not published”; LifeMD publishes “50 states” — for anything short of an explicit 50-state claim, intake is the final word.
Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.
Exit terms: IVIM Health — membership mandatory for duration; membership mandatory. LifeMD — program fee recurs monthly; program fee recurs until cancelled.
Insurance: only LifeMD does coverage work — decisive if there is any chance your plan covers a brand GLP-1, because a covered prescription beats both cash paths on this page.
Evidence: IVIM Health source-verified (captured 2026-08-05); LifeMD third-party reported (2026-08-05).
A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.
In the full tirzepatide index these two sit at #3 and #17 of 17: between them lie 13 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #3 and #20 of 20: between them lie 16 other programs, and the whole ladder is at cheapest semaglutide providers.
Switching between IVIM Health and LifeMD
Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (IVIM Health: membership mandatory; LifeMD: program fee recurs until cancelled) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.
Which one, for whom
Cheapest tirzepatide month-to-month: IVIM Health ($278).
Cheapest 12-month path: IVIM Health at $3,336 (monthly billing).
Cheapest semaglutide: IVIM Health ($149).
If insurance might cover you: LifeMD — the only one of the two doing coverage work, and a covered brand prescription beats both cash paths.
Reduced to a sentence each: IVIM Health is the arithmetic answer at $278 all-in; LifeMD is the answer only if what its extra $319/month buys — membership services — appears on your personal ledger; and insurance coverage, wherever it exists, is the answer that beats both. The calculator settles the residue at your own horizon.
Verdicts are computed from the records above — recompute them from the dataset. Full profiles: IVIM Health · LifeMD.
Frequently asked
Which is cheaper, IVIM Health or LifeMD?
On tirzepatide, IVIM Health is cheaper: $278 versus $597 a month all-in — a $319 monthly gap, $3,828 across a year of maintenance dosing. On semaglutide, IVIM Health is cheaper: $149 versus $348 a month all-in — a $199 monthly gap, $2,388 across a year of maintenance dosing.
Is there a membership fee at IVIM Health or LifeMD?
IVIM Health: $75/month, mandatory and already included in the figures here. LifeMD: $149/month, included in the figures here.
Where do these numbers come from?
From each provider's own published pages, captured 2026-08-05 (IVIM Health) and 2026-08-05 (LifeMD), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.
What does a year of tirzepatide cost at IVIM Health vs LifeMD?
IVIM Health: $3,336 monthly-billed. LifeMD: $7,164. Best-path difference: $3,828 in favor of IVIM Health.
What does a year of semaglutide cost at IVIM Health vs LifeMD?
IVIM Health: $1,788 monthly-billed. LifeMD: $4,176. Best-path difference: $2,388 in favor of IVIM Health.
Is IVIM Health or LifeMD dose-flat?
IVIM Health: no flat structure verified — get the maintenance-dose price in writing. LifeMD: yes — flat across doses. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.
Can I check both IVIM Health and LifeMD against their sources?
Yes — that is the design. Each record carries a capture date (2026-08-05 / 2026-08-05), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.
What states do IVIM Health and LifeMD serve?
IVIM Health: not published. LifeMD: 50 states. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.
Is shipping included at IVIM Health and LifeMD?
IVIM Health: included. LifeMD: included. Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.
Which is more transparent, IVIM Health or LifeMD?
On the checkable axes: pharmacy named — IVIM Health no, LifeMD no; state list — IVIM Health published, LifeMD published; cancellation terms — IVIM Health published, LifeMD published; evidence — source-verified vs third-party reported. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.